- Category : Healthcare
- Region : APAC
- Publishing Date : 06/30/2022
Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity
Asia Pacific organ transplant diagnostics market will grow by 10.8% annually with a total addressable market cap of $12,042.8 million over 2022-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 31 tables and 58 figures, this 123-page report “Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country.
Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Test Kits & Consumables
o Kits & Assays
o Consumables
• Software & Services
Based on Transplant, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
• Stem Cell Transplant
• Soft Tissue Transplant
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostics
o Donor Testing
o Recipient Testing
• Translational Research
By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
• Serology
• Flow Cytometry
• Other Technologies
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Transplant Centers
• Reference Laboratories
• Academic and Research Institutions
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
List of Tables:
Table 1. Snapshot of Asia Pacific Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. World Health Spending by Region, $ bn, 2013-2020 32
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Organ Transplant Diagnostics Market 36
Table 6. Asia Pacific Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 44
Table 7. Main Platforms and Key Vendors 47
Table 8. Asia Pacific Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn 48
Table 9. Main Kits & Assays and Key Vendors 50
Table 10. Main Consumables and Key Vendors 52
Table 11. Main Services and Key Vendors 54
Table 12. Asia Pacific Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 55
Table 13. Asia Pacific Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn 58
Table 14. Asia Pacific Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn 68
Table 15. Asia Pacific Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn 70
Table 16. Asia Pacific Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 74
Table 17. Asia Pacific Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn 77
Table 18. Asia Pacific Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn 84
Table 19. APAC Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 91
Table 20. Japan Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 95
Table 21. Japan Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 95
Table 22. Japan Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 95
Table 23. China Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 97
Table 24. China Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 97
Table 25. China Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 97
Table 26. Australia Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 99
Table 27. Australia Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 99
Table 28. Australia Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 99
Table 29. India Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 101
Table 30. India Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 101
Table 31. India Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 101
Table 32. South Korea Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 103
Table 33. South Korea Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 103
Table 34. South Korea Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 103
Table 35. Organ Transplant Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 105
Table 36. Abbott Laboratories Inc.: Company Snapshot 110
Table 37. Abbott Laboratories Inc.: Business Segmentation 111
Table 38. Abbott Laboratories Inc.: Product Portfolio 111
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Asia Pacific Market by Offering 44
3.1 Market Overview by Offering 44
3.2 Instruments 46
3.3 Test Kits & Consumables 48
3.3.1 Kits & Assays 49
3.3.2 Consumables 51
3.4 Software & Services 53
4 Segmentation of Asia Pacific Market by Transplant 55
4.1 Market Overview by Transplant 55
4.2 Solid Organ Transplant 57
4.2.1 Kidney 59
4.2.2 Liver 60
4.2.3 Heart 61
4.2.4 Lung 62
4.2.5 Pancreas 63
4.2.6 Kidney-Pancreas 64
4.2.7 Other Solid Organ Transplants 65
4.3 Stem Cell Transplant 66
4.4 Soft Tissue Transplant 67
5 Segmentation of Asia Pacific Market by Application 68
5.1 Market Overview by Application 68
5.2 Diagnostics 70
5.2.1 Donor Testing 71
5.2.2 Recipient Testing 72
5.3 Translational Research 73
6 Segmentation of Asia Pacific Market by Technology 74
6.1 Market Overview by Technology 74
6.2 Molecular Technologies 76
6.2.1 PCR 78
6.2.2 Sequencing 79
6.2.3 Other Molecular Technologies 80
6.3 Serology 81
6.4 Flow Cytometry 82
6.5 Other Technologies 83
7 Segmentation of Asia Pacific Market by End User 84
7.1 Market Overview by End User 84
7.2 Hospitals and Transplant Centers 86
7.3 Reference Laboratories 87
7.4 Academic and Research Institutions 88
7.5 Other End Users 89
8 Asia-Pacific Market 2021-2031 by Country 90
8.1 Overview of Asia-Pacific Market 90
8.2 Japan 93
8.3 China 96
8.4 Australia 98
8.5 India 100
8.6 South Korea 102
8.7 Rest of APAC Region 104
9 Competitive Landscape 106
9.1 Overview of Key Vendors 106
9.2 New Product Launch, Partnership, Investment, and M&A 109
9.3 Company Profiles 110
Abbott Laboratories Inc. 110
ARUP Laboratories 112
BAG Health Care GmbH 113
Becton Dickinson and Company 114
bioMérieux S.A. 115
Bio-Rad Laboratories, Inc. 116
CareDx, Inc. 117
Eurofins Scientific 118
F. Hoffmann-La Roche Ltd. 119
Illumina, Inc. 120
Immucor, Inc. 121
Laboratory Corporation of America Holdings 122
Novacyt Group 123
Omixon Ltd. 124
OPKO Health 125
QIAGEN N.V. 126
Quest Diagnostics Incorporated 127
Thermo Fisher Scientific Inc. 128
RELATED REPORTS 129